Cancer stem cell in breast cancer therapeutic resistance-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cancer stem cell in breast cancer therapeutic resistance

Published:2018-09 Issue: Volume:69 Page:152-163
ISSN:0305-7372
Container-title:Cancer Treatment Reviews
language:en
Short-container-title:Cancer Treatment Reviews

Author:

Bai Xupeng,Ni Jie,Beretov Julia,Graham Peter,Li Yong

Funder

St George Cancer Care Centre Research Trust Fund

Prostate and Breast Cancer Foundation

UNSW Sydney

China Scholarship Council

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Reference100 articles.

1. Cancer statistics, 2017;Siegel;CA Cancer J Clin,2017

2. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials;Clarke;Lancet,2005

3. The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation;Phillips;J Natl Cancer Inst,2006

4. Aspirin suppresses the acquisition of chemoresistance in breast cancer by disrupting an NFkappaB-IL6 signaling axis responsible for the generation of cancer stem cells;Saha;Cancer Res,2016

5. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell;Bonnet;Nat Med,1997

Cited by 223 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the role of RNA methylation in glioma: Mechanisms, prognostic biomarkers, and therapeutic targets;Cellular Signalling;2024-12

2. ALDH and cancer stem cells: Pathways, challenges, and future directions in targeted therapy;Life Sciences;2024-11

3. Integrated machine learning algorithms identify KIF15 as a potential prognostic biomarker and correlated with stemness in triple-negative breast cancer;Scientific Reports;2024-09-13

4. Caffeic acid inhibits the tumorigenicity of triple-negative breast cancer cells through the FOXO1/FIS pathway;Biomedicine & Pharmacotherapy;2024-09

5. tsRNA-GlyGCC promotes colorectal cancer progression and 5-FU resistance by regulating SPIB;Journal of Experimental & Clinical Cancer Research;2024-08-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3